Method for generating immune-compatible cells and tissues using nuclear transfer techniques
A cell and tissue technology used in the field of verifying or evaluating the immunocompatibility of these tissues to avoid transplant rejection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
Embodiment 1
[0070] This experiment was designed to test the immunocompatibility of cells produced by nuclear transfer in a large preclinical animal model: bovine (Bos tauras).
[0071] Three adult Holstein castrated cattle (approximately 500-1000 lbs) approximately 8-10 months of age were purchased from Thomas Morris Company (Maryland) and shipped to South Deerfield Ranch at the University of Massachusetts (Amherst). To obtain fibroblasts for nuclear transfer, skin biopsies were obtained from each animal through an ear incision. A plasmid expressing a reporter gene encoding enhanced green fluorescent protein (eGFP) was transfected into these cells, and transfected cells were selected with neomycin. Purified cells analyzed by PCR and / or FISH were used for nuclear transfer as previously described (Nature (1998) Biotechnol. 16:642-646, incorporated herein by reference).
[0072] Embryos with more than one cell isolated from bovine blastocyst / stem cells, or blastodisc / inner cell mass or stem...
Embodiment 2
[0076] This example is designed to test teratoma formation in an immunocompromised animal model. This example relates to the method by which nuclear transfer-producing cells from patients in need of transplantation can be grown in SCID mice or other immunocompromised animals so as to produce differentiated cells for isolation and engineering of engineered tissues for transplantation .
[0077] ES cells transfected with GFP were derived from two adult Holstein castrated cattle (two different ES cell lines were obtained from each animal). ICMs were derived from day 12 blastocysts.
[0078] Cell preparation and injection procedure:
[0079] Cells are diced (cuts of no more than about 100 cells each) and filled into 1 ml syringes, not more than 200 μl, preferably 100 μl per syringe.
[0080] The ICMS was mechanically dissociated and filled into 1 ml syringes in 100-500 μl volumes.
[0081] Cells were maintained in HECM-Hepes at room temperature.
[0082] mouse#
d...
Embodiment 3
[0094] In order to realize the full potential of therapeutic cloning, it will be important to reconstitute more complex tissues and organs in vitro. While cloning could eliminate or greatly alleviate the most critical problem—immune compatibility—there is the hard work of assembling these cells together to generate or regenerate functional structures.
[0095] For example, myocardial infarction is one of the most common diagnoses occurring in patients seeking medical care in Western countries. Although injecting single or small groups of cardiomyocytes can help treat small focal infarcts, this approach is useful in patients with greater ischemic injuries who are at greater risk of scarring, heart rupture, and other complications. Impossible to have value. Tissue engineering offers the possibility of organizing cells into three-dimensional cardiac muscle "patches" that can be used to repair damaged parts of the heart. For heart muscle and other relatively simple tissues such ...
PUM
Property | Measurement | Unit |
---|---|---|
Diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com